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Recombinant l-i chain I’crritins bearing site-dirucled amino acid substitutions al their l’crroxidasc ccntrcs have bee11 used to study the mechanism 
ot-calalysis ol’ Fc(I1) oxidation by this protein. UV-dffercncc spectra huve been obtainctl ut vurious times ahcr the aerobic addition ol’Fc(ll) to 
the recombii;arlts, Thcsc indicllte that the tirst product ol’Fc(H) oxidation by wild type H chain apoferritin is an Be(lll)y-oxombridged dimcr. This 
suggests that fast oxidation is achieved by 24cctron transfer liom two Fe(11) to dioxyyen. Modclling oTFe(lll) dimrr binding to human H chain 
apoferritin shows a solvent-accessible site, which rcscmbles that 01’ ribonuclcotidc reduclasu in its liyands. Substitution of these ligands by other 
nmino acids usually prcvcnts dimcr Ibrmution and leads to greatly reduced Fc(ll) oxidarior. rates. 
Ferritin; Fcrroxidnsc cntre; Iron (111) oxo-bridged imcr; Iron (111) monomer 
1. INTRODUCTION 
Fcrritin plays an essential role in iron metabolism. Its 
ability to sequester iron is important both because it 
husbands an essential element and because free iron is 
potentially toxic. The ferritin molecule is a hollow shell 
built from 24 protein subunits in which iron is deposited 
as ferrihydrite, an Fe(lII) hydrolysis product [I]. Apo- 
ferritin subunits are of two types, H and L, which co- 
operate in ferrihydrite production [2], Each H chain 
contains a ferroxidase centre at which Fe(H) oxidation 
is catalyscd so that Fe(III) is provided rapidly for fer- 
rihydrite nucleation [3-61. L chains lack these centres, 
but their cavity-faces favour nucleation because lhey are 
relatively rich in carboxylic amino acids [(il. Here, how- 
ever, our main concern is to explain how H chains 
catalyse Fe(II) oxidation. 
Mdssbauer spectroscopic measurements have shown 
that when Fe(I1) is added in air at pH 7.0 to recombi- 
nant human H chain apoferritin (8 or 38 Fe/mol, 0.5 
mM Fe), oxidation is complete in under 1 min [7]. The 
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Iron (111) at I min is in the form of isolated Fe(II1) 
atoms (20%), y-oxo-bridged Fe(II1) dimers (70%) and 
small Fe(II1) clusters (10%). Although isolated Fe(II1) 
species are observed, Fe(III) dimers are not formed 
when Fe( II) is added to an H chain variant in which two 
residues at the ferroxidase centre are changed [7]. With 
this variant, Fe(ll) ox’idation was even slower than in 
the protein-free control (in which neither monomer nor 
dimcr Fe(lI1) was seen). Here we report changes in UV- 
difference spectra after Fe(I1) addition to recombinant 
human H chain apoferritin variants bearing one or 
more amino acid substitution at their ferroxidase cen- 
tres. 
Previously it has been found by X-ray crystallogra- 
phy that the ferroxidase centres of human H chains bind 
TbJ+ ions at two alternative positions about 3.1 A apart 
[5]. Ligands of these metal sites, Glu-27, Glu-61, Glu- 
62, His-65 and Glu-107, are conserved in mammalian 
H chains, as are two residues which hydrogen bond to 
Glu- 107, namely Tyr-34 and Gin-141 [2]. Several of 
these residues have been replaced for our spectroscopic 
study. Another conserved residue, Ala-144, near the 
ferroxidase centre, may also be essential for activity 
because its replacement by a larger residue (Leu as in 
L chains) seems to impede access from or to cavity. A 
computer graphics diagram of the centre is shown in 
Fig. I modelled with a Au-oxo-bridged Fe(II1) dimer in 
place. We propose that these dimers are the product of 
r’upid oxidation from a pair of Fe(Ii) aloms and that this 
accounts for the catalytic action of the ferroxidase cen- 
tre. 
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Fig. I. Proposed site of tile p-o&o-bridged iron dimcr with bound 
dioxygcn. The iigurc is based on the coordinates ofhumun H fcrritin 
151. The iron labefled FcA shows octtihcdrul coordination. with a water 
tnolecuie (WAT) in the sixth position, whilst FeB shows tetrahedral 
coordiltation. Metal-to-ii~~nd bonds are in the range 1.84 A (0X0) 
to 235 A (H@), with an Fe-Fe ~cparatio1~ of 3.25 A and an FcaO-Fc 
angle of 125.‘, Hydrogen bonds are indicated by thin ditshcd tines, The 
mctul site is viewed from the internal cavity. Rotation about the 
Ccc-Cfi bond allows Clu~61 to swing into the c;lvity. The model WBS 
produced using the molecular modclling program FRODO [I!)]. im- 
plcmcnled on an Evans and Sutherland series ‘V’ stereo workstation 
and the drawing WUY produced using the ptickugc MOLSCRIPT [20]. 
2. MATERIALS AND METHODS 
Site directed muttig,encais, overexpression in Eklwricltirr rnli and 
puritication of recombinant human H chain fcrritins were performed 
as in [S]. Iron was removed from the fcrritins with sodium dithionitc 
accordilly to [7], Alter reduction, the protein was puriiicd by ion 
exchange chromatography wirh Q Scpharosc Fust Flow (Phtiri-nticia. 
Milton Keynes, UK), The protein in BBS was absorbed on a column 
(1.6 x 14 cm) cquilibratcd with 0.05 M MES. pH 6.2 (buffer A), and 
washed with three column volumes of buffer A before alution ut I 
mUmin with a snlt gradient. The latter was formed using un LKl3 
(Pharmacis) HPLC Gradient Controller from buf&r A and 0.5 M 
NaCl in buffer A as solvent B. The gradient corresponded to 0.4% 
B/min, Ferri:in containing fractions with a ~8~~6D nm absorbance 
ratio > I .?. were pooled, concenlratcd. ialysed against IO mM NaCl 
in an 8MC ultra~itratiojl cell (Amicon, High Wycombe. UK) and 
stored at 4OC. Bovine strum albumin (BSA) WJS from Sigma (Pooic, 
Dorset, UK). 
2.2. v v rf~J2rPr,cr spcl’rrosrvp) 
Spectra wcrc recorded using a Cary I spcctrophotomctur, The apo- 
ferritin solution (I mg/ml) in MES bufkr was placed in both sample 
and blank compnrtmcnts and a base lint recorded. 0.5 ~1 H,O was 
added to the blank and 0.5,ul (NH,j2Fc(S0,), (Aldrich. UK, 49.997% 
pure) solution added to the sample to give a final concentration of 8.4 
KM. The spectrophoton~eter was Set to record rcpcatcd spectra at 
citlter 1 or 5 min intervals, 
3. RESULTS AND DISCUSSION 
Examples of UV different spectra are shown in Fig. 
2 a-f. Each figure shows successive spectra obtained at 
the times indicated after the addition of (NH,&Fe(SO& 
to the recombinant human H chain apoferritin (4 Fe(If)/ 
molecule) or to BSA. The spectra shown in Fig. 2b,c, 
d and c are of recombinant human H ferritin with one 
or more amino acid substitution at the fcrroxidase ten- 
tre. In the sample of Fig. 2a this centre is intact. Samples 
in Fig. ?a-d arc at pH 6.5 and 2e at pH 7.5. Fig. 2f 
shows spectra obtained during the oxidation of Fe(lI) 
at pH 7.0 in the presence of BSA used as control protein 
(bellaving as a protective ~lloid). The rate of oxidation 
at pH 6.5 was negligible. Except for the sample in Fig. 
2d and e, the ferritins bear a substitution Lys-86/Gin, 
remote from the ferroxidase centre, introduced to allow 
crystallization through metal bridge formation and 
hence X-ray analysis [5]. In all the samples, spectral 
changes with time are seen, giving essentially four types 
of pattern: i I ) shown in Fig. 2a and d, (2) in Fig. 2b and 
c, (3) in Fig. 2e and (4) in Fig. 2f, The spectra of Fig. 
2f are featureless. Similar spectra, without any absorb- 
ance rnaxiin~, have also been obtained with rat or 
humall L ferritin under similar conditions. Patterns like 
those of Fig. 2b and c, in which a single absorbance 
maximum dcv&ps in khc region of 290 nm, have ken 
obtained when any of the seven ferroxidase centre resi- 
dues are substituted, except for Glu-61 (and Gin-141 
which has not yet been examined). In the sample of Fig. 
2d and e the substitution Glu-bl/Ala has been made 
along with Glu-64/Ala and Glu-67/Ala. Similar spectra 
wcrc obwined in a sample containing only the Glu-61/ 
Ala substitution. Glu-64 and -67 lie on the inside surface 
of the ~~poferritin shell, but Glu-61 can occupy one of 
two different positions in the crystal electron de~lsity, 
one parti~ipatillg in the ferroxidase centre (Fig. 1) and 
the other pointing into the cavity. It has been po:;tulated 
that movement of this residue may assist he migration 
of Fe”’ from the oxidation site to the nucleation site [5]. 
In all the examples of Fig. _ 9 absorbance changes occur 
over a period of several minutes after the recording of 
the first spectrum. However, in Fig. 2a and d the first 
absorbing species is gradually replaced by another and 
the spectra intersect at an isosbestic point. The first 
spectrun~ in Fig, 2d, obtained at pH 6.5, shows two 
shoulders at approximate1~ 3 10 and 350 nm and similar 
shoulders are even more evident in Fig, 2e. However, at 
the higher pH value, 7.5, this absorbing species is rela- 
tively stable. Its spectrum bears a strong resemblance to
the 300-400 nm region of the spectra of oxyhaem- 
erythrin and ribonucleotide reductase, the two shoul- 
ders being attributed in these proteins to ligand-to- 
metal charge transfer bands of their Ir_oxo-bridged 
Fe(lII) dimers [9?,10]. WC propose that the 310 and 350 
nm absorbances of Fig, 2d and e represent LMT C 
bitnds of such dimers attached to ferritin H chains. Fig. 
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Fig. 2. UV direrence spectra of recombinant human H chuin apoferritins slier the addition of4 Fe(lI)/apofcrritin as (N H4)2Pe(S04)2. Thcapoferritin 
in a (CdM) bears a single amino acid substitution Lys-SblGln on the outside surface 01” the protein shell. b and c carry this change in addition to 
those at the fcrro.ridasc ccntre shown. In d and e, Cilu-Gl is lbund alternatively at the ferroxidasc ccntrc or on the cavity surfitce. and Glu-64 and 
GIu-67 x-c on the Iruter. 
2d shows the disappearance over several minutes at pH 
6.5 of the dimcr spectrum and its replacement by a 
species absorbing in the region of 290 nm, essentially 
like those of Fig. 2b and c. Similar behaviour at this PI-I 
is suggested in Fig. 2a, although the dimer bands are 
now barely visible. We suggest hat in these recombi- 
nants the 290 nm absorbance results from dimer cleav- 
age. It could represent acomposite of two single Fc(III) 
species, and could also have a contribution arising from 
the movement of an aromatic residue or residues. 
In variants howing only the 290 nm absorbance such 
as those of Figs. 2b and c, maximum absorbance is 
reached much more slowly t!lzn tka& of the di:ner ab- 
sorbancc of Fig. 2a,d and e, but at very different rates 
in different variants. We associate the slow appearance 
of the 290 nm absorbance with slow Fe(II) oxidation 
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(this has been demonstrated by Mtjssbauer spectros- 
copy for one variant (Glu-62/Lys, His-65/Gly) in which 
oxidation took over 2.5 h to complete [7]). In contrast, 
oxidation is complete in about 1 min for variants with 
intact ferroxidase centres 17,111. In protein-free con- 
trols, in the presence of BSA, Fig. 2f, or in rat or human 
L chain recombinant ferritins, Fe(U) oxidation is again 
very slow compared to that in the presence of human 
H chain ferritin. 
We suggest on the basis of the present experiments 
(combined with the Mossbauer data) that, in wild-type 
ferritin, oxidation at the ferroxidasc entre proceeds 
according to Scheme 1. with the binding of two %(I!) 
in close proximity enabling 2-electron transfer to a diox- 
ygen molecule. Oxidation is followed by the splitting of 
the dinuclear species (Scheme 2). The oxidative step of 
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Schcmc 9. Splitting ol’p-oxo-bridged I%( 1 II) dimcr. 
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Scheme 1 is similar to that proposed for the binding of 
dioxygen to haemerythrin [9], but the reaction now pro- 
ceeds to the formation of H,O,. 
It is suggested that reversible oxygenation in prefer- 
ence to oxidation in haemerythrin is enabled by the 
non-polar character of its dioxygen binding site which 
retards the release of the negatively charged HOO- ion 
[9] and the production of hydrogen peroxide (as in 
scheme 1) is slow compared with dioxygen binding and 
Z-electron transfer [9]. In H chain ferritin, however, the 
dimer site is relatively open and accessible to water. In 
haemerythrin dimer dissociation tends to be proton as- 
sisted [9], Dimer dissociation (scheme 2) which in fer- 
ritin H chains may enable iron to be released from the 
ferroxidasc entre for ferrihydrite nucleation in the cav- 
ity, is also l’avoured at lower pH. The formation of 
fcrrihydrite, however, is favoured by pH values above 
7 [I?]. due to the release of protons associated with 
hydrolytic poiymerisation. This explains why iron-core 
formation proceeds in L chains homopoiymers (lacking 
ferroxidase centres) only at pH 7 or above. 
Consistent with our proposed mechanism, we note 
that evidence for the production of peroxide during the 
oxidation of 24 Fe(Ii) added to horse spleen apoferritin 
has been obtained by Xu and Chasteen [13]. Cheng and 
Chastcen 1141 found that the rate of disappearance of
Fe(U) was first, not second, order as might be expected 
from scheme 1, but, under the conditions used, dimer 
production may not have been rate-limiting. 
A computer graphics drawing of the ferroxidase cen- 
tre region of human H chain apoferritin is shown in Fig. 
I. A p-oxo-bridged Fe(llI) dimcr (Fe-Fe distance 3.25 
A, Fe’o‘Fe angle 115O) has been placed in a space 
which is part of an inlet from the central cavity. Fe 
iigands are shown in Fig. 1. There is space for a dioxy 
gen molecule to bind to FeA. with the possibility of 
hydrogen bonding from a y-hydroxo hydrogen and this 
has been modelled, The site, which resembles that of 
ribonucieotide reductase [15] more closely in its iigands 
than that of haemerythrin [9], shows considerable side 
chain flexibility and the two Fe”’ atoms are modeiled 
at similar. but not identical positions to those described 
previously for TbJ+ [5]. In the proposed model a single 
carboxyiale, Giu-62, bridges the two Fe atoms. Bridg- 
ing ulso by Glu-107 may be possible [5] if this residue 
and the two metal atoms are placed in somewhat differ- 
ent positions. FeA also has Glu-27 and His-65 as Ii- 
gands and Fe6 has Giu-107 and Giu-61 (when appro- 
priately orientated as in Fig. 1). Substitution of ei&er 
site A or site E3 ligands seems to prevent dimer forma- 
tion. In principle. monomer Fe(II1) could be produced 
by le- transfer to O2 at either A or B since both are 
accessible to Oz. In one of the variants giving only the 
190 nm absorbance (Giu-62/Lys. His-BSIGiy), and in 
which monomer, but no dimer, Fc(IIJ) has been ob- 
served by Mtissbauer spectroscopy [I, iigands of both 
Fe atoms are altered and the position of the dimer is 
now occupied by a salt bridge between Lys-62 and Giu- 
107 (as found in L chains). Monomer Fe(III) cannot 
therefore be at either site A or B in this variant and its 
iocalion is at present uncertain. 
In summary the work prcscnted here suggests that 
‘ferroxidase activity’ may be accounted for by fast 2-e- 
transfer to a pair of Fe(I1) at the ferroxidase centrc, 
rotlowed by Fe(iIl) dimcr dissocialion and migration 
into the cavity, When dimer formation is prevented, a
slow, presumably le- oxidation is possible. Formation 
of Fe dimers is co-operative since even when only 4 
Fe(I1) atoms are added to the H chain 24-mer. ail or 
most of the iron appears in this foi,m immediately after 
oxidation. The precise steps following dimer dissocia- 
lion and the location of the early products remain to be 
elucidated. However. we know that monomer Fe(II1) 
[7, I I, 161 as well as the 290 nm absorbance [ 171 gradu- 
ally diminish as ferrihydrite clusters grow. Once the iron 
core has formed, it provides an ailernative surfacc for 
Fe(I1) oxidation which allows the reduction of4 Fe(U)/ 
O2 and the reduction of dioxygen to water [I 3,181. 
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